These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10072628

  • 1. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T, Miyagawa I.
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [Abstract] [Full Text] [Related]

  • 2. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.
    Zhu Z, Xing S, Cheng P, Li G, Yang Y, Zeng F, Lu G.
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):354-7. PubMed ID: 15587397
    [Abstract] [Full Text] [Related]

  • 3. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.
    Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S.
    Cancer Lett; 2000 Nov 28; 160(2):199-208. PubMed ID: 11053650
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST, Jin YT, Leung HW, Wang ST, Tsao CJ, Su IJ.
    Anticancer Res; 1998 Nov 28; 18(4B):2849-54. PubMed ID: 9713473
    [Abstract] [Full Text] [Related]

  • 5. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G, Chiacchio R, Reggiardo G, De Sanctis D, Manzione L.
    Tumour Biol; 2004 Nov 28; 25(5-6):258-63. PubMed ID: 15627889
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical study of bcl-2, p53 and Ki-67 expressions in collecting duct carcinoma of the kidney. Five cases and review of the literature on bcl-2, p53 and Ki-67 expressions in renal cell carcinoma and transitional cell carcinoma.
    Suzuki K, Tokue A.
    Urol Int; 2002 Nov 28; 69(1):57-62. PubMed ID: 12119441
    [Abstract] [Full Text] [Related]

  • 7. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
    Nguyen VN, Mirejovský P, Mirejovský T, Melínová L, Mandys V.
    Acta Histochem; 2000 Aug 28; 102(3):323-38. PubMed ID: 10990069
    [Abstract] [Full Text] [Related]

  • 8. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, Georgountzos C, Thomas-Tsagli E.
    Pathol Res Pract; 1997 Aug 28; 193(11-12):767-75. PubMed ID: 9521509
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct.
    Suto T, Sugai T, Nakamura S, Uesugi N, Sasaki R, Kanno S, Saito K.
    Oncology; 1997 Aug 28; 54(5):407-13. PubMed ID: 9260603
    [Abstract] [Full Text] [Related]

  • 10. Expression of the antiapoptotic protein bcl-2 is not dependent on the tumor suppressor p53 protein in Indian breast carcinoma.
    Kesari AL, Chellam VG, Madhavan J, Nair PP, Nair MK, Pillai MR.
    Pathobiology; 1997 Aug 28; 65(2):108-12. PubMed ID: 9253035
    [Abstract] [Full Text] [Related]

  • 11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 28; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 12. Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
    Lee CT, Genega EM, Hutchinson B, Fearn PA, Kattan MW, Russo P, Reuter VE.
    Urol Oncol; 2003 May 28; 21(3):179-84. PubMed ID: 12810203
    [Abstract] [Full Text] [Related]

  • 13. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D, Moutzouris G, Barbatis C, Presvelos V, Petrakos M, Theodorou C.
    Eur J Surg Oncol; 1999 Feb 28; 25(1):61-5. PubMed ID: 10188857
    [Abstract] [Full Text] [Related]

  • 14. Tumour suppressor protein (p53), apoptosis inhibiting protein (Bcl-2) and proliferating cell nuclear antigen (PCNA) expressions in a rat pancreatic tumour model.
    Mäkinen K, Loimas S, Hakala T, Eskelinen M.
    Anticancer Res; 2007 Feb 28; 27(1A):23-6. PubMed ID: 17352211
    [Abstract] [Full Text] [Related]

  • 15. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G, Wittmann A, Dammrich J, Bassukas ID.
    Anticancer Res; 1996 Feb 28; 16(6B):3807-11. PubMed ID: 9042262
    [Abstract] [Full Text] [Related]

  • 16. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K.
    Anticancer Res; 2005 Feb 28; 25(5):3437-43. PubMed ID: 16101161
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Cancer; 1996 Jan 01; 77(1):164-71. PubMed ID: 8630925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.